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1. Introduction {#ejp1074-sec-0006}
===============

Fear and anxiety have been implicated in many aspects of pain, including experimentally induced pain intensity (George et al., [2006](#ejp1074-bib-0013){ref-type="ref"}; Parr et al., [2012](#ejp1074-bib-0039){ref-type="ref"}), pain during dental care (van Wijk and Hoogstraten, [2009](#ejp1074-bib-0052){ref-type="ref"}), chronic pain behaviour (McCracken et al., [1996](#ejp1074-bib-0025){ref-type="ref"}; Vlaeyen et al., [2001](#ejp1074-bib-0049){ref-type="ref"}; Turk et al., [2004](#ejp1074-bib-0048){ref-type="ref"}) and pain‐related disability (Crombez et al., [1999](#ejp1074-bib-0010){ref-type="ref"}; Buer and Linton, [2002](#ejp1074-bib-0007){ref-type="ref"}; Lee et al., [2007](#ejp1074-bib-0020){ref-type="ref"}). As fear and anxiety, along with depression, are integral to understanding pain, valid and time‐efficient assessments of such phenomena are needed. Currently, available instruments are useful, but due to mounting pressures in healthcare to improve efficiency and see more patients in increasingly shorter periods of time (Okie, [2012](#ejp1074-bib-0037){ref-type="ref"}; Bodenheimer and Smith, [2013](#ejp1074-bib-0005){ref-type="ref"}), briefer assessments are needed.

One such widely used and studied fear of pain instrument is the Fear of Pain Questionnaire‐III (FPQ‐III; McNeil and Rainwater, [1998](#ejp1074-bib-0029){ref-type="ref"}). Although a few studies have identified limitations (Asmundson et al., [2008](#ejp1074-bib-0003){ref-type="ref"}), the original FPQ‐III factor structure and items have continued to be widely used and validated (Hursey and Jacks, [1992](#ejp1074-bib-0018){ref-type="ref"}; Osman et al., [2002](#ejp1074-bib-0038){ref-type="ref"}; Roelofs et al., [2005](#ejp1074-bib-0043){ref-type="ref"}). In addition, the FPQ‐III has been translated and used in other languages such as French and Dutch (Albaret et al., [2004](#ejp1074-bib-0002){ref-type="ref"}; van Wijk and Hoogstraten, [2006](#ejp1074-bib-0051){ref-type="ref"}), and used in a variety of healthcare settings (Zvolensky et al., [2001](#ejp1074-bib-0054){ref-type="ref"}).

In addition to the FPQ‐III, there are several other published instruments which assess fear and anxiety associated with pain, each with a different focus. Regardless of the scale (or subscale) name, all of them assess both fear and anxiety, as disentangling those constructs for measurement is extraordinarily difficult. The Pain Anxiety Symptoms Scale (PASS; McCracken et al., [1992](#ejp1074-bib-0024){ref-type="ref"}) is a 40‐item measure that assesses pain‐related fear and anxiety; it is used in this study and so is more fully described under the Methods section. The Fear Avoidance Beliefs Questionnaire (FABQ) is a 16‐item measure that assesses beliefs about how work and physical activity affect pain, and is particularly well suited for assessing degree of work‐related disability in chronic pain patients (Waddell et al., [1993](#ejp1074-bib-0050){ref-type="ref"}). Finally, the Tampa Kinesiophobia Scale (TSK) is a 17‐item measure that assesses pain‐related fear of re‐injury, which also is available in a shortened version of 11 items (Woby et al., [2005](#ejp1074-bib-0053){ref-type="ref"}).

The aim of this study was to develop and establish a shortened version of the FPQ‐III that could reduce time and staff demands in clinical and research settings, reduce respondent fatigue and possibly be used as a screening instrument. The Fear of Pain Questionnaire‐9 (FPQ‐9) was designed to mirror its parent version (i.e. to use existing items and to maintain its three‐factor structure). The purpose of this study was to develop and test a short (i.e. nine items) assessment instrument that paralleled the original FPQ‐III (McNeil and Rainwater, [1998](#ejp1074-bib-0029){ref-type="ref"}). This paper describes the process of testing the FPQ‐9 as a brief, reliable and valid assessment of fear and anxiety associated with pain, for clinical and research purposes.

2. Data and methods {#ejp1074-sec-0007}
===================

2.1. Instruments {#ejp1074-sec-0008}
----------------

### 2.1.1. Fear of Pain Questionnaire‐III {#ejp1074-sec-0009}

The FPQ‐III is a 30‐item self‐report questionnaire composed of three subscales: Fear of Severe Pain, Fear of Minor Pain and Fear of Medical/Dental Pain (McNeil and Rainwater, [1998](#ejp1074-bib-0029){ref-type="ref"}). Using a 5‐point Likert‐type scale, higher scores indicated more fear. The scale has high test--retest reliability (*r *=* *0.92) and high internal consistency (α = 0.74), as do each of the subscales (McNeil and Rainwater, [1998](#ejp1074-bib-0029){ref-type="ref"}). Other researchers have confirmed the original three‐factor structure and high internal consistency of the FPQ‐III (Osman et al., [2002](#ejp1074-bib-0038){ref-type="ref"}; Roelofs et al., [2005](#ejp1074-bib-0043){ref-type="ref"}). The FPQ‐III has been used to help identify patients with pain‐related fear and anxiety that is high enough to negatively impact their experience of medical and dental procedures and their overall quality of life (Sperry‐Clark et al., [1999](#ejp1074-bib-0047){ref-type="ref"}; McNeil et al., [2001](#ejp1074-bib-0033){ref-type="ref"}; LeMay et al., [2011](#ejp1074-bib-0021){ref-type="ref"}). The FPQ‐III also has been used in basic research on the effects of fear on acute pain (Carter et al., [2002](#ejp1074-bib-0008){ref-type="ref"}; Hirsh et al., [2008](#ejp1074-bib-0016){ref-type="ref"}). Asmundson et al. ([2008](#ejp1074-bib-0003){ref-type="ref"}) developed a different revised and shortened form of the original FPQ‐III with the purpose to evaluate alternative factorial models; however, their final questionnaire still had 23 items, only seven fewer than the original scale. Parr et al. ([2012](#ejp1074-bib-0039){ref-type="ref"}) used the present 9‐item shortened version of the FPQ‐III, in its unpublished format and with permission from the test developers (McNeil and Rainwater, [1998](#ejp1074-bib-0029){ref-type="ref"}), to determine the relation between fear of pain and pain intensity. The FPQ‐9 demonstrated high internal consistency (ICC = 0.83--0.87, compared with 0.94--0.95 for the 30‐item version), and was highly correlated with the original FPQ‐III (*r *=* *0.94--0.97), as well as participant report of pain intensity (*r *=* *0.29), severity of disability (*r *=* *0.16), scores on the Pain Catastrophizing Scale (*r *=* *0.35) and scores on the Tampa Kinesiophobia Scale (*r *=* *0.34). The Parr study, however, did not address other psychometric properties of the FPQ‐9, utilized only total score with no attention paid to subscales and the factor structure of the instrument, and did not include a clinical sample; thus, the present study aimed to present the FPQ‐9 more comprehensively and with richer psychometric analyses.

### 2.1.2. Pain Anxiety Symptoms Scale {#ejp1074-sec-0010}

The PASS (McCracken et al., [1992](#ejp1074-bib-0024){ref-type="ref"}) is a 40‐item self‐report measure that assesses pain‐related fear and anxiety, and consists of four subscales: Cognitive Anxiety, Fear, Escape/Avoidance, and Physiological Anxiety. Using a 5‐point Likert‐type scale, higher scores are indicative of more anxiety and fear. McCracken and Dhingra ([2002](#ejp1074-bib-0023){ref-type="ref"}) developed a shortened PASS, but still consisting of 20 items; it has been criticized for having wordy items and 'uncertain' (p. 46) psychometric properties (Grimmer‐Somers et al., [2009](#ejp1074-bib-0014){ref-type="ref"}).

### 2.1.3. Dental Fear Survey {#ejp1074-sec-0011}

The DFS (Kleinknecht et al., [1973](#ejp1074-bib-0019){ref-type="ref"}) is a 20‐item self‐report measure that assess dental care‐related anxiety and fear on a continuum (McNeil and Randall, [2014](#ejp1074-bib-0030){ref-type="ref"}). With a 5‐point Likert‐type scale, higher scores reflect greater fear and anxiety.

The DFS consists of three factorially derived subscales: Behavioral Avoidance, Physiological Responses and Fear of Specific Stimuli (McGlynn et al., [1987](#ejp1074-bib-0027){ref-type="ref"}).

There has been extensive psychometric testing of the DFS, confirming its reliability, validity, and utility (e.g. Heaton et al., [2007](#ejp1074-bib-0015){ref-type="ref"}; McNeil and Randall, [2014](#ejp1074-bib-0030){ref-type="ref"}).

2.2. Participants {#ejp1074-sec-0012}
-----------------

### 2.2.1. Patients with chronic pain {#ejp1074-sec-0013}

The FPQ‐III data were previously collected (Sperry‐Clark et al., [1999](#ejp1074-bib-0047){ref-type="ref"}) on 275 outpatients (112 men and 163 women; M age = 45.6 years, SD = 12.0) with chronic pain at the West Virginia Pain Treatment Center in Morgantown, WV, and so served as part of an archival dataset. (This sample was collected to match the undergraduate group, detailed subsequently, in terms of total number and gender distribution.) These data, along with a second, new sample of 100 outpatients with chronic pain seeking outpatient treatment (43 men, 50 women, 7 unknown gender) with complete data from the aforementioned facility, were utilized in this study. Newly acquired participants were between the ages of 18 and 65 with a mean age of 48.5 (SD = 13.7). Institutional Review Board (IRB) approval was secured for data collection; all participants provided written and oral informed consent.

To collect data from a new sample of participants with chronic pain, individuals were approached in the waiting room of the West Virginia Pain Treatment Center. These 100 new participants were randomly divided into two groups. Group 1 (*n *=* *55) provided demographic information and completed the existing FPQ‐III directly before the appointment. Immediately following the appointment, these participants in Group 1 (25 men, 25 women and 5 unknown gender) completed the new FPQ‐9. Group 2 (*n *=* *45), which consisted of 18 men, 25 women and 2 participants of unknown gender, followed the same procedure except with reversal of presentation of the FPQ‐III and the FPQ‐9. Along with the FPQ‐9 and demographic questionnaire, each chronic pain outpatient in the new sample also completed an omnibus fear item (i.e. \#20) from the Dental Fear Survey (DFS; Kleinknecht et al., [1973](#ejp1074-bib-0019){ref-type="ref"}): 'All things considered, how fearful are you of having dental work done?'.

### 2.2.2. Students {#ejp1074-sec-0014}

Archival FPQ‐III data from 275 undergraduates (112 men and 163 women; M age = 19.7 years, SD = 3.2) from Oklahoma State University were used in this study (McNeil and Rainwater, [1998](#ejp1074-bib-0029){ref-type="ref"}). (This sample was matched with the 275 chronic pain patients in terms of total number and gender distribution.) In addition, a new sample of 190 college students (70 men and 120 women) with a mean age of 20.1 (SD = 3.5) were obtained from the West Virginia University Department of Psychology. As for data collection with the chronic pain patient samples, IRB approval was obtained and all participants provided written and oral informed consent.

Data collection with the new sample of West Virginia University undergraduates took place over the course of two sessions at the conclusion of an academic class period, in classrooms that seated approximately 60 students. In total, there were 190 volunteer undergraduate students (70 men and 120 women); they received extra credit in their introductory psychology course for their participation. Undergraduate participants completed a demographic questionnaire, and then were randomly assigned to either Group 1 (*n *=* *97) or Group 2 (*n *=* *93). Order of measures were counterbalanced such that during the first data collection session, Group 1 completed the FPQ‐III, and Group 2 was given the FPQ‐9, the PASS (McCracken et al., [1992](#ejp1074-bib-0024){ref-type="ref"}), and the entire 20‐item DFS (Kleinknecht et al., [1973](#ejp1074-bib-0019){ref-type="ref"}; McGlynn, [1998](#ejp1074-bib-0026){ref-type="ref"}). One week later, these same students returned and completed the other tests; Group 1 (38 men and 59 women) received the FPQ‐9, PASS, and the DFS, while Group 2 (32 men and 61 women) was given the existing FPQ‐III.

2.3. Analytic approach {#ejp1074-sec-0015}
----------------------

### 2.3.1. Item selection {#ejp1074-sec-0016}

Literature on scale development suggests that any single factor or subscale includes at least three items to avoid them being poorly defined (Brown, [2015](#ejp1074-bib-0006){ref-type="ref"}). Thus, in order to maintain the original FPQ‐III three‐factor structure, and to equate the number of items across each of the three factors, a 9‐item scale was the goal. Quantitative information was used to determine which items to include in the brief form as outlined in the following sections, along with theoretically based judgements to mimic broad representation of the constructs.

### 2.3.2. Item‐total correlations {#ejp1074-sec-0017}

Data from all 30 items of the FPQ‐III available from the 550 respondents in the archival dataset (275 chronic pain outpatients and 275 undergraduates) were subjected to item‐total correlation analysis. Separate item‐total correlations calculated for the pain patients and the undergraduates were essentially the same, so only combined data are reported. Items first were considered based upon their correlation value (see Table [1](#ejp1074-tbl-0001){ref-type="table-wrap"}). After considering the individual items' correlation value, three items were selected from each of the original subscales (i.e. Fear of Severe Pain, Fear of Minor Pain and Fear of Medical/Dental Pain) that most comprehensively and broadly represented the factors in the parent scale, from a theoretical perspective.

###### 

Item‐total correlations for the subscales of the FPQ‐III

  FPQ‐III Item \# and Item:     *r*                                                                                
  ----------------------------- ---------------------------------------------------------------------------------- ------
  Fear of Medical/Dental pain                                                                                      
  8\.                           Having a blood sample drawn with a hypodermic needle                               0.63
  11\.                          Receiving an injection in your arm                                                 0.62
  14\.                          Receiving an injection in you hip/buttocks                                         0.68
  15\.                          Having a deep splinter in the sole of your foot probed and removed with tweezers   0.64
  16\.                          Having an eye doctor remove a foreign particle stuck in your eye                   0.51
  17\.                          Receiving an injection in your mouth                                               0.69
  20\.                          Receiving stitches in your lip                                                     0.67
  21\.                          Having a foot doctor remove a wart from your foot with a sharp instrument          0.66
  26\.                          Having a tooth pulled                                                              0.65
  29\.                          Having one of your teeth drilled                                                   0.66
  Fear of Minor Pain                                                                                               
  2\.                           Biting your tongue while eating                                                    0.56
  4\.                           Cutting your tongue licking an envelope                                            0.59
  7\.                           Hitting a sensitive bone in your elbow‐your 'funny' bone                           0.64
  12\.                          Burning your fingers with a match                                                  0.58
  19\.                          Getting a papercut on your finger                                                  0.70
  22\.                          Cutting yourself while shaving with a sharp razor                                  0.64
  23\.                          Gulping a hot drink before it has cooled                                           0.67
  24\.                          Getting strong soap in both your eyes while bathing or showering                   0.69
  28\.                          Having sand or dust blow into your eyes                                            0.63
  30\.                          Having a muscle cramp                                                              0.57
  Fear of Severe Pain                                                                                              
  1\.                           Being in an automobile accident                                                    0.64
  3\.                           Breaking your arm                                                                  0.75
  5\.                           Having a heavy object hit you in the head                                          0.76
  6\.                           Breaking your leg                                                                  0.80
  9\.                           Having someone slam a heavy car door on your hand                                  0.81
  10\.                          Falling down a flight of concrete stairs                                           0.77
  13\.                          Breaking your neck                                                                 0.79
  18\.                          Being burned on your face by a lit cigarette                                       0.70
  25\.                          Having a terminal illness that causes you daily pain                               0.69
  27\.                          Vomiting repeatedly because of food poisoning                                      0.63

*n *=* *550 (275 chronic pain patients and 275 undergraduates).

John Wiley & Sons, Ltd

After item selection, an exploratory factor analysis (EFA) on the archival data (*n *=* *550) and a confirmatory factor analyses (CFA) on the new data (i.e. 100 pain patients and 190 undergraduates) were used to test the decisions described previously. Conducting the EFA and CFA on different datasets allowed for cross‐validation of the assumed factor structure and model fit.

### 2.3.3. Exploratory factor analysis {#ejp1074-sec-0018}

The exploratory factor analysis (EFA) was conducted using Mplus 7.4 (Muthén & Muthén, [1998](#ejp1074-bib-0701){ref-type="ref"}--2015). The EFA first was conducted with the assumption that the Likert‐type items were continuous and then as categorical. The EFA included a full information maximum likelihood estimator (MLR) for the continuous analysis and the WMSLV estimator for the categorical analysis. The Mplus default---a geomin, oblique rotation method---provided estimated factor loadings for each item.

### 2.3.4. Confirmatory factor analysis {#ejp1074-sec-0019}

Utilizing the new dataset (*n *=* *290), the CFA was conducted with the items as categorical and continuous; the model with continuous items fit the data markedly better. Because of improved model fit, the full information likelihood (MLR) estimator was used in subsequent analyses. Based on modification indices reported in Mplus, a second CFA included a 'WITH' statement for items 14 and 17 (which allowed the items to be correlated) and improved model fit.

### 2.3.5. Reliability {#ejp1074-sec-0020}

To test for internal consistency, coefficient alpha was calculated for each of the subscales individually as well as for the total score. Alpha was chosen because of its familiarity in the literature and because, with a short‐form assessment, it is not susceptible to the same downfalls as longer assessments (e.g. inflated reliability as a function of length, similar grammar/statement structure; DeVellis, [2017](#ejp1074-bib-0011){ref-type="ref"}). The heuristic cutoff of α ≥ 0.70 was used in determining adequate reliability (Nunnally, [1978](#ejp1074-bib-0036){ref-type="ref"}).

### 2.3.6. Validity {#ejp1074-sec-0021}

In addition to factor validity, which was assessed *vis‐à‐vis* model fit indices, convergent validity was examined by correlating the FPQ‐9 total score with PASS scores derived from the 190 participants in the new dataset. Concurrent validity was tested with respondents who completed both the FPQ‐9 and FPQ‐III. Convergent validity also was evaluated comparing FPQ‐9 responses to those of the PASS and the DFS. The DFS was chosen for analysis of convergent validity given that fear of pain has been shown to be a primary component (McNeil and Berryman, [1989](#ejp1074-bib-0028){ref-type="ref"}) and strong predictor (Randall et al., [2016](#ejp1074-bib-0041){ref-type="ref"}) of dental care‐related fear, and because dental care‐related fear is prevalent, with wide variability, among the general population (Milgrom et al., [2009](#ejp1074-bib-0035){ref-type="ref"}). Moreover, the DFS can simultaneously be used for the analysis of convergent and divergent validity across FPQ‐9 subscales, given that the FPQ‐9 has a subscale assessing fear of Medical/Dental Pain (with expected large associations with DFS scores) and two subscales that are not specifically related to Medical/Dental Pain (each with expected smaller associations with DFS scores).

3. Results {#ejp1074-sec-0022}
==========

3.1. Item‐total correlations {#ejp1074-sec-0023}
----------------------------

The item‐total correlations are reported in Table [1](#ejp1074-tbl-0001){ref-type="table-wrap"} and were used to determine how each item from the original FPQ‐III correlated with its intended subscale or factor (i.e. Fear of Severe Pain, Fear of Minor Pain, Fear of Medical/Dental Pain). Item‐total correlation coefficients, theoretical and pragmatic justifications were used in choosing three items for each of the three subscales, to mirror the parent FPQ‐III and its structure of three factors, each consisting of an equal number of 10 items.

For all selected items, the Flesch Reading Ease statistic is 70.0 and the Flesch‐Kincaid Grade Level is 6.3, suggesting appropriate readability. The final measure has a public domain copyright and is included in Appendix [A](#ejp1074-app-0001){ref-type="app"}, with scoring criteria in Appendix [B](#ejp1074-app-0002){ref-type="app"}.

3.2. Exploratory factor analyses {#ejp1074-sec-0024}
--------------------------------

The factor loading results of the EFA using the archival data (i.e. 275 outpatients and 275 undergraduates) are described in Table [2](#ejp1074-tbl-0002){ref-type="table-wrap"}. All items loaded successfully on their intended factor, with factor loadings of above 0.40 and without cross‐loading within 0.15, with the exception of item 21 ('I fear the pain associated with having a foot doctor remove a wart from your foot with a sharp instrument') from the original FPQ‐III scale. This item cross‐loaded on two different factors, but was retained as an attempt to maintain the original factor structure of the parent instrument and because it did not prevent excellent model fit. This justification led to retention of that item and allowed proceeding to the confirmatory factor analysis phase to assess if the factor structure and model fit held in a different sample.

###### 

Exploratory factor analysis of geomin‐rotated factor loadings for three‐factor model

  FPQ‐III Item   Fear of Severe Pain                           Fear of Moderate Pain                         Fear of Medical Pain
  -------------- --------------------------------------------- --------------------------------------------- ---------------------------------------------
  3\.            0.761[a](#ejp1074-note-0004){ref-type="fn"}   −0.042                                        −0.004
  9\.            0.852[a](#ejp1074-note-0004){ref-type="fn"}   0.026                                         0.006
  10\.           0.914[a](#ejp1074-note-0004){ref-type="fn"}   0.000                                         −0.166
  14\.           −0.005                                        0.856[a](#ejp1074-note-0004){ref-type="fn"}   −0.133
  17\.           0.042                                         0.688[a](#ejp1074-note-0004){ref-type="fn"}   0.002
  19\.           0.000                                         0.107                                         0.583[a](#ejp1074-note-0004){ref-type="fn"}
  21\.           0.377[a](#ejp1074-note-0004){ref-type="fn"}   0.351[a](#ejp1074-note-0004){ref-type="fn"}   0.089
  23\.           0.015                                         −0.004                                        0.770[a](#ejp1074-note-0004){ref-type="fn"}
  24\.           −0.005                                        0.001                                         0.784[a](#ejp1074-note-0004){ref-type="fn"}

*p *\<* *0.05.
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Model fit statistics from the EFA are reported in Table [3](#ejp1074-tbl-0003){ref-type="table-wrap"}. As mentioned previously, a three‐factor structure produced good to excellent fit. This finding served as reason to proceed to the CFA phase of the analysis. As the EFA revealed no significant difference when the variables were treated as categorical compared to continuous ones, results for handling the data as continuous variables are reported.

###### 

Model fit when extracting various factor structures from the exploratory factor analysis

  Number of factors extracted   RMSEA   CFI     TLI     SRMR
  ----------------------------- ------- ------- ------- -------
  One‐factor                    0.176   0.763   0.683   0.090
  Two‐factor                    0.121   0.921   0.851   0.052
  Three‐factor                  0.034   0.996   0.988   0.012

RMSEA, Root Mean Square Error of Approximation; CFI, Confirmatory Fit Index; TLI, Tucker--Lewis Index; SRMR, Standardized Root Mean Square Residual.

John Wiley & Sons, Ltd

3.3. Confirmatory factor analysis {#ejp1074-sec-0025}
---------------------------------

Using the new data (*n *=* *290; 190 undergraduates and 100 outpatient pain patients), two CFA models were tested. The first CFA was performed with the items as categorical and the second with items as continuous. The continuous CFA produced better model fit (see Table [4](#ejp1074-tbl-0004){ref-type="table-wrap"}) and subsequently was used for the final CFA. Utilizing the modification indices function in MPlus, two of the items (14 and 17) in the Fear of Medical/Dental Pain subscale were allowed to be correlated, which subsequently produced a well‐fitting model as seen in Table [4](#ejp1074-tbl-0004){ref-type="table-wrap"}.

###### 

Model fit indices produced by confirmatory factor analyses

  Model                                              RMSEA   CFI     TLI     SRMR
  -------------------------------------------------- ------- ------- ------- -------
  Three‐factor (categorical)                         0.118   0.954   0.931   1.005
  Three‐factor (continuous)                          0.072   0.950   0.925   0.048
  Three‐factor (continuous) and 14 & 17 correlated   0.000   1.000   1.000   0.027

The three‐factor model was categorical and fit statistic was WRMR instead of SRMR. RMSEA, Root Mean Square Error of Approximation; CFI, Confirmatory Fit Index; TLI, Tucker--Lewis Index; SRMR, Standardized Root Mean Square Residual.

John Wiley & Sons, Ltd

3.4. Examination of possible order effects {#ejp1074-sec-0026}
------------------------------------------

To assess possible order effects across two instruments of differing lengths, a mean single‐item rating was derived for each of the forms of the FPQ. No differences were observed across FPQ‐III (M* *=* *2.5, SD = 0.71) and FPQ‐9 scores (M* *=* *2.5, SD = 0.74), *t*(289) = 0.25, *p *=* *0.80. Also, a *t*‐test was conducted between the mean score for whichever test was first administered (M* *=* *2.5, SD = 0.71) and the mean score for whichever test was administered second (M* *=* *2.5, SD = 0.74), similarly yielding no differences, *t*(289) = 0.24, *p *=* *0.81.

3.5. Psychometric properties of the FPQ‐9 {#ejp1074-sec-0027}
-----------------------------------------

### 3.5.1. Internal consistency {#ejp1074-sec-0028}

Cronbach\'s alpha was calculated for the FPQ‐9 total score and three subscales, yielding values from 0.72 to 0.94. Table [5](#ejp1074-tbl-0005){ref-type="table-wrap"} presents these results.

###### 

Alpha coefficients for FPQ‐9 and FPQ‐III subscales and total scores

                                FPQ‐9   FPQ‐III
  ----------------------------- ------- ---------
  Subscale                              
  Fear of Severe Pain           0.84    0.92
  Fear of Minor Pain            0.72    0.89
  Fear of Medical/Dental Pain   0.73    0.89
  Total score                   0.83    0.94

FPQ‐9, Fear of Pain Questionnaire -- 9; FPQ‐III, Fear of Pain Questionnaire -- III; *n* = 290.

John Wiley & Sons, Ltd

### 3.5.2. Validity {#ejp1074-sec-0029}

As a measure of concurrent validity, correlations were conducted between the FPQ‐III and FPQ‐9 subscale and total scores for the new data (i.e. 100 pain patients and 190 undergraduates). Correlations were strong for all scale scores, with *p *\<* *0.01 for each analysis: Total score -- *r *=* *0.77; Fear of Severe Pain -- *r *=* *0.73; Fear of Minor Pain -- *r *=* *0.67; and Fear of Medical/Dental Pain -- *r *=* *0.76. Additionally, as a measure of convergent validity, correlations were conducted between the DFS' omnibus fear item \#20 with the FPQ‐9 scores. For the undergraduates, these scores also were compared with the full‐length DFS total and subscale scores. Table [6](#ejp1074-tbl-0006){ref-type="table-wrap"} presents these results. As expected, the FPQ‐9 subscale with the highest correlations (all moderate to high) with DFS total score, subscale scores and Item \#20 score was the Fear of Medical/Dental Pain subscale, an indication of convergent validity. Also as expected, lower correlations between the FPQ‐9 Fear of Severe Pain subscale score and DFS total score, subscale scores, and Item \#20 score suggest divergent validity. Correlations were calculated for FPQ‐9 and FPQ‐III in comparison to PASS scores as a measure of convergent validity, as shown in Table [7](#ejp1074-tbl-0007){ref-type="table-wrap"}. Moderate correlations across the board indicate good convergent validity and also suggest that the two measures tap similar, but distinct constructs.

###### 

Correlations among the subscales of the FPQ‐9, FPQ‐III and DFS

            Dental Fear Survey                                                                                                                                                                  
  --------- -------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- --------------------------------------------
  FPQ‐9                                                                                                                                                                                         
  Severe    0.22[a](#ejp1074-note-0009){ref-type="fn"}   0.32[a](#ejp1074-note-0009){ref-type="fn"}   0.22[a](#ejp1074-note-0009){ref-type="fn"}   0.28[a](#ejp1074-note-0009){ref-type="fn"}   0.19[a](#ejp1074-note-0009){ref-type="fn"}
  Minor     0.28[a](#ejp1074-note-0009){ref-type="fn"}   0.33[a](#ejp1074-note-0009){ref-type="fn"}   0.25[a](#ejp1074-note-0009){ref-type="fn"}   0.31[a](#ejp1074-note-0009){ref-type="fn"}   0.20[a](#ejp1074-note-0009){ref-type="fn"}
  Medical   0.45[a](#ejp1074-note-0009){ref-type="fn"}   0.57[a](#ejp1074-note-0009){ref-type="fn"}   0.43[a](#ejp1074-note-0009){ref-type="fn"}   0.53[a](#ejp1074-note-0009){ref-type="fn"}   0.41[a](#ejp1074-note-0009){ref-type="fn"}
  Total     0.38[a](#ejp1074-note-0009){ref-type="fn"}   0.49[a](#ejp1074-note-0009){ref-type="fn"}   0.36[a](#ejp1074-note-0009){ref-type="fn"}   0.45[a](#ejp1074-note-0009){ref-type="fn"}   0.33[a](#ejp1074-note-0009){ref-type="fn"}
  FPQ‐III                                                                                                                                                                                       
  Severe    0.21[a](#ejp1074-note-0009){ref-type="fn"}   0.30[a](#ejp1074-note-0009){ref-type="fn"}   0.21[a](#ejp1074-note-0009){ref-type="fn"}   0.26[a](#ejp1074-note-0009){ref-type="fn"}   0.10[a](#ejp1074-note-0009){ref-type="fn"}
  Minor     0.32[a](#ejp1074-note-0009){ref-type="fn"}   0.31[a](#ejp1074-note-0009){ref-type="fn"}   0.24[a](#ejp1074-note-0009){ref-type="fn"}   0.32[a](#ejp1074-note-0009){ref-type="fn"}   0.22[a](#ejp1074-note-0009){ref-type="fn"}
  Medical   0.45[a](#ejp1074-note-0009){ref-type="fn"}   0.57[a](#ejp1074-note-0009){ref-type="fn"}   0.37[a](#ejp1074-note-0009){ref-type="fn"}   0.52[a](#ejp1074-note-0009){ref-type="fn"}   0.35[a](#ejp1074-note-0009){ref-type="fn"}
  Total     0.39[a](#ejp1074-note-0009){ref-type="fn"}   0.47[a](#ejp1074-note-0009){ref-type="fn"}   0.33[a](#ejp1074-note-0009){ref-type="fn"}   0.44[a](#ejp1074-note-0009){ref-type="fn"}   0.26[a](#ejp1074-note-0009){ref-type="fn"}

FPQ‐9, Fear of Pain Questionnaire -- 9; FPQ‐III, Fear of Pain Questionnaire -- III; DFS, Dental Fear Survey.

*p *\<* *0.01.

*n *=* *177 undergraduates; data missing for 13 undergraduates.

*n *=* *288 (100 chronic pain patients and 188 undergraduates; data missing for two participants).

John Wiley & Sons, Ltd

###### 

Correlations among the subscales of the FPQ‐9 and the PASS

            PASS                                                                                                                                                                                
  --------- -------------------------------------------- -------------------------------------------- -------------------------------------------- -------------------------------------------- --------------------------------------------
  FPQ‐9                                                                                                                                                                                         
  Severe    0.35[a](#ejp1074-note-0013){ref-type="fn"}   0.38[a](#ejp1074-note-0013){ref-type="fn"}   0.34[a](#ejp1074-note-0013){ref-type="fn"}   0.30[a](#ejp1074-note-0013){ref-type="fn"}   0.40[a](#ejp1074-note-0013){ref-type="fn"}
  Minor     0.35[a](#ejp1074-note-0013){ref-type="fn"}   0.32[a](#ejp1074-note-0013){ref-type="fn"}   0.31[a](#ejp1074-note-0013){ref-type="fn"}   0.20[a](#ejp1074-note-0013){ref-type="fn"}   0.34[a](#ejp1074-note-0013){ref-type="fn"}
  Medical   0.42[a](#ejp1074-note-0013){ref-type="fn"}   0.45[a](#ejp1074-note-0013){ref-type="fn"}   0.34[a](#ejp1074-note-0013){ref-type="fn"}   0.36[a](#ejp1074-note-0013){ref-type="fn"}   0.46[a](#ejp1074-note-0013){ref-type="fn"}
  Total     0.46[a](#ejp1074-note-0013){ref-type="fn"}   0.48[a](#ejp1074-note-0013){ref-type="fn"}   0.41[a](#ejp1074-note-0013){ref-type="fn"}   0.36[a](#ejp1074-note-0013){ref-type="fn"}   0.50[a](#ejp1074-note-0013){ref-type="fn"}

FPQ‐9, Fear of Pain Questionnaire -- 9; PASS, Pain Anxiety Symptoms Scale; *n *=* *190 undergraduates.

*p *\<* *0.01.

John Wiley & Sons, Ltd

4. Discussion and conclusions {#ejp1074-sec-0030}
=============================

The aim of the current study was to create a shortened (i.e. fewer than 10 item) version of an instrument that measures fear of pain in clinical and basic research settings. The intent was to allow for time‐efficient administration and scoring without sacrificing the accuracy or other psychometric properties of the longer instrument. These results provide psychometric evidence for the comparability of the FPQ in its full‐length and current shortened FPQ‐9 versions. The three subscales of the FPQ‐III (i.e. Fear of Severe Pain, Fear of Minor Pain, and Fear of Medical/Dental Pain) were well represented and maintained in the FPQ‐9 subscales. The similarity between the items that were selected as result of high item‐total correlations and through factor analyses reinforces their representative strength as items in the FPQ‐9 subscales. The factor loadings for the FPQ‐9 were acceptable, especially given the adequate to good model fit produced by the analyses. The final factor structure tested in the CFA would be the recommended measurement model to initiate any subsequent analyses, regression or structural equation models (SEM) in further studies using the FPQ‐9.

The FPQ‐9 provides a more efficient measure of fear of pain than other measures of the construct, including the FPQ‐9\'s predecessor (the FPQ‐III), which is an important strength. In fact, given that the number of items is reduced by more than two‐thirds, there is a substantial savings in administration and scoring time; the FPQ‐9 is the most economical instrument currently available. The full‐length FPQ‐III takes approximately 4--5 min to complete, and 3--4 min for the healthcare provider/researcher to score. Conversely, the FPQ‐9 takes about 2 min or less to complete and less than 1 min to score. Subscale scores are calculated by summing the three items in each subscale (e.g. Fear of Severe Pain subscale is calculated by summing values for items 1, 6 and 9). The total score then is determined by summing the three subscale scores. Additional scoring information is available in Appendix [B](#ejp1074-app-0002){ref-type="app"}.

As clinicians generally have stringent demands placed on their time (Linzer et al., [2015](#ejp1074-bib-0022){ref-type="ref"}; Shaw et al., [2014](#ejp1074-bib-0045){ref-type="ref"}), shortened assessment instruments that adequately and accurately measure constructs of interests are understood to be ideal for clinical application. Evidence from the current study suggests that the FPQ‐9 is reliable and valid measure of fear and anxiety associated with pain and, at only 9 items, the instrument may be particularly well‐suited for use in medical, dental, rehabilitation and pain clinics, among other clinical contexts. The FPQ‐9 can be administered and scored easily in a few minutes. Addressing fear of pain in certain clinical populations has the potential to improve treatment outcome, pain experience and overall patient condition.

There are at least two apparent benefits to the utilization of this shorter measure in the research context. First, participants completing shorter instruments presumably are less likely to experience participant fatigue (Sitzia and Wood, [1997](#ejp1074-bib-0046){ref-type="ref"}; Ben‐Nun, [2008](#ejp1074-bib-0004){ref-type="ref"}; Hoerger, [2010](#ejp1074-bib-0017){ref-type="ref"}; Randall et al., [2013](#ejp1074-bib-0040){ref-type="ref"}). Second, shorter assessment tools provide opportunity for the researcher to include additional measures in the spirit of more comprehensive evaluation. Of course, balance must be achieved between limiting participant fatigue and the thoroughness of assessment. The FPQ‐9 exemplifies a significant step in the shortening of a commonly used measurement instrument, for the benefit of pain research. An additional strength of this shortened version of the FPQ‐III is that each item maintains the wording used in the parent instrument, and so use of the FPQ‐9 in languages other than English potentially could rely upon prior translations of the FPQ‐III (e.g. Dutch; van Wijk and Hoogstraten, [2009](#ejp1074-bib-0052){ref-type="ref"}).

In spite of the inclusion of both clinical and nonclinical samples, and careful methodological rigor, this study has some limitations. First, the FPQ‐9, while including three dimensions like its parent instrument, still only assesses fear via self‐report, so it, along with other questionnaire measures, is inherently limited. Second, the FPQ‐9 likely measures both fear and anxiety, as do all currently extant instruments in this area. Although pain‐related fear and anxiety are separate states (McNeil et al., [1993](#ejp1074-bib-0032){ref-type="ref"}, [2001](#ejp1074-bib-0033){ref-type="ref"}, [2012](#ejp1074-bib-0034){ref-type="ref"}; Craske, [2003](#ejp1074-bib-0009){ref-type="ref"}; McNeil and Vowles, [2004](#ejp1074-bib-0031){ref-type="ref"}), the current state of the science is that fear and anxiety about pain are measured jointly, even though some scale titles (or subscale titles) would suggest otherwise. The FPQ‐9 should be administered with the understanding that both fear and anxiety are being measured; future development of assessment tools that measure fear or anxiety, disentangling the two, may be warranted. A third limitation is that the length of time between the first and second administrations of the two versions of the FPQ differed between the pain outpatients and undergraduates, due to logistical constraints. Also, the fact that a pain clinic appointment intervened between the administrations for the outpatients introduces unknown variance. Finally, these development studies did not include measures of pain itself, either chronic or acute, and either current and/or past, which would have strengthened the methodology. Nevertheless, the results presented here demonstrate the strength of the FPQ‐9, constructed within contemporary recommendations for short‐form development (Adams, [2000](#ejp1074-bib-0001){ref-type="ref"}; Reise et al., [2000](#ejp1074-bib-0042){ref-type="ref"}), are most encouraging.

There still is a place for the full‐length FPQ‐III, and other, longer pain‐related fear and anxiety assessments. When issues of fear and anxiety are suspected in pain patients, or in research that focuses on the relation between fear/anxiety and pain, the full‐length FPQ‐III (or similar instruments, depending on the research or clinical question at hand), may be the most appropriate choice to allow the most comprehensive assessment.

This study of a truly shortened short form of the FPQ‐III suggests that the FPQ‐9 has overall good psychometric properties. Still, additional research is necessary to confirm the factor structure of the FPQ‐9 in other and more diverse samples and settings. Test--retest reliability and construct validity of the FPQ‐9 also should be the subject of future research. Additionally, future work should seek to establish FPQ‐9 norms for the general population as well as specific clinical groups.

Emotions, particularly fear and anxiety, have an important role in the experience of both acute and chronic pain (Romano and Turner, [1985](#ejp1074-bib-0044){ref-type="ref"}; Hursey and Jacks, [1992](#ejp1074-bib-0018){ref-type="ref"}; McCracken et al., [1992](#ejp1074-bib-0024){ref-type="ref"}; Geisser et al., [1994](#ejp1074-bib-0012){ref-type="ref"}; Hirsh et al., [2008](#ejp1074-bib-0016){ref-type="ref"}). Comprehensive assessment of problem emotional states likely will first depend on accurate screening, using an instrument that is sufficiently brief, accurate, and accessible to a variety of patient and nonclinical populations. The FPQ‐9 has promise as such a short, respondent‐completed instrument that will allow for more patient‐centred care while still providing useful information to help guide further assessment and treatment.
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Name:\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_ Date:\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_\_

**INSTRUCTIONS:** The items listed below describe painful experiences. Please look at each item and think about how **FEARFUL** you are of experiencing the **PAIN** associated with each item. If you have never experienced the **PAIN** of a particular item, please answer on the basis of how **FEARFUL** you expect you would be if you had such an experience. Circle one number for each item below to rate your **FEAR OF PAIN** in relation to each event.

I FEAR the PAIN associated with:Not at allA littleA fair amountVery muchExtreme1.Breaking your arm123452.Having a foot doctor remove a wart from your foot with a sharp instrument123453.Getting a papercut on your finger123454.Receiving an injection in your mouth123455.Getting strong soap in both your eyes while bathing or showering123456.Having someone slam a heavy car door on your hand123457.Gulping a hot drink before it has cooled123458.Receiving an injection in your hip/buttocks123459.Falling down a flight of concrete stairs12345[^1]

 {#ejp1074-sec-0034}

Score the Fear of Severe Pain subscale by summing values for the following items: 1, 6, 9Score the Fear of Minor Pain subscale by summing values for the following items: 3, 5, 7Score the Fear of Medical/Dental Pain subscale by summing values for the following items: 2, 4, 8Calculate the Total Score by summing the three subscale values, or simply sum all 9 items. (You may wish to calculate the Total Score both ways, to check for possible errors.)

Each subscale contains 3 items, so the possible range of scores for each subscale is 3 through 15. The Total score has a range of 9 through 45.

The 9 items of the FPQ‐9 items correspond exactly to those in the 30 item Fear of Pain Questionnaire as follows:

FPQ‐9 Item \#FPQ‐III Item \#1322131941752469723814910

[^1]: The FPQ‐9 is copyrighted by the authors. Permission is given for users to reproduce the instrument for clinical and research purposes.
